# BioNexus Gene Lab Corp: Form SCHEDULE 13D, filed Aug 14, 2026

- Company: [BioNexus Gene Lab Corp](/companies/bglc.md) (CIK 1737523)
- Form: SCHEDULE 13D
- Filed: 2026-08-14
- Accepted by EDGAR: Aug 14, 2026, 21:29 ET
- Period: not reported
- Accession: 0001520138-26-000354
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1737523/000152013826000354/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737523/000152013826000354/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737523/000152013826000354/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Aug 14, 2026.
Source: SEC EDGAR, the filing index for accession 0001520138-26-000354. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.
